Santen Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 4.70% vs -2.40% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 83.07% vs 6,807.32% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80,861.00",
          "val2": "77,231.00",
          "chgp": "4.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21,627.00",
          "val2": "17,526.00",
          "chgp": "23.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "512.00",
          "val2": "1,400.00",
          "chgp": "-63.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15,554.00",
          "val2": "8,496.00",
          "chgp": "83.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "211.10%",
          "val2": "170.00%",
          "chgp": "4.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -2.79% vs -0.65% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 4.77% vs 34.27% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "291,624.00",
          "val2": "300,004.00",
          "chgp": "-2.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "63,573.00",
          "val2": "74,179.00",
          "chgp": "-14.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,391.00",
          "val2": "1,083.00",
          "chgp": "28.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3,872.00",
          "val2": "-10,140.00",
          "chgp": "61.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37,552.00",
          "val2": "35,844.00",
          "chgp": "4.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "155.00%",
          "val2": "187.40%",
          "chgp": "-3.24%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

80,861.00

77,231.00

4.70%

Operating Profit (PBDIT) excl Other Income

21,627.00

17,526.00

23.40%

Interest

512.00

1,400.00

-63.43%

Exceptional Items

0.00

0.00

Consolidate Net Profit

15,554.00

8,496.00

83.07%

Operating Profit Margin (Excl OI)

211.10%

170.00%

4.11%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 4.70% vs -2.40% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 83.07% vs 6,807.32% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

291,624.00

300,004.00

-2.79%

Operating Profit (PBDIT) excl Other Income

63,573.00

74,179.00

-14.30%

Interest

1,391.00

1,083.00

28.44%

Exceptional Items

-3,872.00

-10,140.00

61.81%

Consolidate Net Profit

37,552.00

35,844.00

4.77%

Operating Profit Margin (Excl OI)

155.00%

187.40%

-3.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -2.79% vs -0.65% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 4.77% vs 34.27% in Mar 2025

All Annual Results